So I've had a bit of a read of this a couple times.. As with all these types of releases, if you;re not a nutty professor yourself it takes a bit to digest all the big words.
Big takeaway from this is that EBC-46 (TT) is effective against all tumour types tested, and the lack of effectiveness against 1 certain strain 'could' be put down to the larger tumours. This is in-line with previous observations across animals, and humans!
